Measles vaccines: WHO position paper
This position paper incorporates the most recent developments in the field of measles and includes removal of introduction criteria for the routine second dose of measles-containing vaccine (MCV2), guidance on when to vaccinate infants from 6 months of age, and guidance on re-vaccination of HIV-infected children receiving highly active anti-retroviral therapy (HAART). It replaces the 2009 WHO position paper on measles vaccines.
|Journal||Weekly epidemiological record|
|Added on||21 March 2019 13:06:54|
Add to Favourites